October 2026

Exposure in Pellets, Hard Gelatin Capsules, Soft Gelatin Capsules & Tablets Manufacturing in OSD Formulation.

B.Sc. / M.Sc. / ITI / Inter / B.Pharm / M.Pharm / M.SC Microbiology, Biotechnology or relevant Life Sciences qualifications.

Degree in sciences, pharmacy or related field or minimum of 2 years pharmacovigilance experience. Excellent attention to detail.

Excellent negotiation skills with external and internal clients. Ability to make decisions independently and proactively. Excellent organizational, planning skills

Shri Prataprao Jadhav, Union Minister of State (Independent Charge) for Ayush and Minister of State for Health & Family Welfare, today emphasised that traditional systems of medicine, when supported by scientific research, appropriate clinical evidence, quality standards and responsible integration, can make a significant contribution to strengthening preventive healthcare and holistic well-being across the world.

The proposal, notified through Gazette Notification G.S.R. 861(E), dated 28 September 2026, seeks to extend advertising restrictions for medicines listed under Schedule H, Schedule H1 and Schedule X to entities holding licences for the sale and distribution of drugs.

Zydus Lifesciences Limited and Formycon AG have announced that the US Food and Drug Administration (USFDA) has accepted the Biologics License Application (BLA) for FYB206, a proposed biosimilar to Keytruda® (pembrolizumab), for review.

DNA-based vaccines are gaining attention as a versatile platform with the potential to reshape preventive and therapeutic immunization. A new review published in Genes & Diseases examines the evolution of DNA vaccination, advances in vaccine delivery technologies and emerging applications in infectious diseases, oncology and future pandemic preparedness.

A new review in Genes & Diseases highlights FTO, an enzyme involved in RNA modification, as a potentially important biomarker and therapeutic target across gastrointestinal cancers. The article brings together current understanding of FTO in gastric, liver, colorectal and pancreatic cancers, revealing a complex role in which the enzyme can both promote and suppress cancer progression depending on biological context.